Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of Patients?

Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of Patients?

Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of Patients?

Tuesday, December 8, 2015 2:00 to 3:00pm EDT

This webinar will provide insight into how cancer drugs are reviewed by Health Canada, through the multi-step decision-making process that determines whether they are covered by public and private formularies. The presenters will host a live question and answer session following the presentation. The presentation will address the following topics:

  • What are the different steps to bring a new cancer drug to patients?
  • Where can patients make a difference?
  • How is the patient role changing?

Gerry Jeffcott is a senior associate at 3Sixty Public Affairs who has almost 25 years of health and pharmaceutical policy experience. He is a recognized expert in the Canadian reimbursement review and approval process for new medications and a sought after commentator on relevant policy questions. 

As CEO of 3Sixty Public Affairs, Bill Dempster helps health charities, businesses and associations understand health policy and effectively engage with governments.   He applies a deep business, health policy, legal and government experience to find mutually beneficial solutions to complex problems.

To register

https://attendee.gotowebinar.com/register/641002455864314625

No Comments

Sorry, the comment form is closed at this time.

Show Buttons
Hide Buttons